In some patients a positive glycaemic response (rise in the plasma glucose concentration of >1.5 mmol/L) following an intramuscular/intravenous injection of glucagon at the time of hypoglycaemia provides supportive evidence [97]. This evidence concerns the gene GCG and Hypoglycemia.